We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+4.21%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$150M
AUM Growth
-$36M
(-19%)
Cap. Flow
-$46M
Cap. Flow
% of AUM
-30.71%
Top 10 Holdings %
Top 10 Hldgs %
41.15%
Holding
341
New
79
Increased
30
Reduced
42
Closed
62
Avg Time Held Equity + Options
3.4
quarters
Top 10 Avg Time Held Equity + Options
1.8
quarters
Top 20 Avg Time Held Equity + Options
2.3
quarters
Avg Time Held Equity only
3.7
quarters
Top 10 Avg Time Held Equity only
2.9
quarters
Top 20 Avg Time Held Equity only
3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.19M |
| 2 |
LL Flooring Holdings, Inc.
LL
|
+$1.02M |
| 3 |
McDonald's
MCD
|
+$949K |
| 4 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$869K |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$845K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$2.08M |
| 2 |
Esperion Therapeutics
ESPR
|
+$1.61M |
| 3 |
NPSP
NPS PHARMACEUTICALS INC
NPSP
|
+$1.07M |
| 4 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
+$1.06M |
| 5 |
Loews
L
|
+$1.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 33.42% |
| 2 | Miscellaneous | 30.29% |
| 3 | Healthcare | 15.66% |
| 4 | Consumer Discretionary | 6.43% |
| 5 | Technology | 5.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
BDBD
126
DELISTED
BOULDER BRANDS INC
BDBD
| $238K | 0.16% |
+25,000
| New | +$256K |
2015 Q1
0 quarters
|
|
127
Agios Pharmaceuticals
AGIO
$1.84B
| $236K | 0.16% |
+2,500
| New | +$280K |
2015 Q1
0 quarters
|
|
|
ISBC
128
DELISTED
Investors Bancorp, Inc.
ISBC
| $234K | 0.16% |
20,000
-5,000
| -20% | -$56.7K |
2014 Q2
3 quarters
|
|
|
CSLT
129
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $233K | 0.16% |
30,000
+5,000
| +20% | +$42.8K |
2014 Q1
4 quarters
|
|
130
Vince Holding Corp
VNCE
$145M
| $232K | 0.15% |
1,250
-250
| -17% | -$56K |
2014 Q2
3 quarters
|
|
|
FCSC
131
DELISTED
Fibrocell Science Inc.
FCSC
| $226K | 0.15% |
3,333
+2,333
| +233% | +$150K |
2013 Q4
5 quarters
|
|
|
NVCN
132
DELISTED
Neovasc Inc.
NVCN
| $225K | 0.15% |
1
| – | – |
2014 Q2
3 quarters
|
|
133
DELISTED
Amicus Therapeutics
FOLD
| $218K | 0.15% |
+20,000
| New | +$176K |
2015 Q1
0 quarters
|
|
|
CLR
134
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $218K | 0.15% |
5,000
-25,000
| -83% | -$1.06M |
2014 Q4
1 quarter
|
|
|
CSBK
135
DELISTED
Clifton Bancorp Inc.
CSBK
| $212K | 0.14% |
15,000
| – | – |
2014 Q2
3 quarters
|
|
|
KKD
136
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
| $200K | 0.13% |
10,000
-5,000
| -33% | -$102K |
2014 Q4
1 quarter
|
|
|
VER
137
DELISTED
VEREIT, Inc.
VER
| $197K | 0.13% |
4,000
| – | – |
2014 Q4
1 quarter
|
|
138
NeoGenomics
NEO
$2.08B
| $187K | 0.12% |
40,000
| – | – |
2014 Q2
3 quarters
|
|
139
Curis
CRIS
$1.56M
| $184K | 0.12% |
38
+13
| +52% | +$62.8K |
2013 Q2
7 quarters
|
|
|
FNM
140
DELISTED
FANNIE MAE
FNM
| $176K | 0.12% |
75,000
+25,000
| +50% | +$58.7K |
2014 Q4
1 quarter
|
|
141
Globalstar
GSAT
$10.8B
| $167K | 0.11% |
3,333
| – | – |
2013 Q4
5 quarters
|
|
142
Green Brick Partners
GRBK
$2.66B
| $166K | 0.11% |
20,000
-5,000
| -20% | -$38.7K |
2014 Q4
1 quarter
|
|
143
HomeTrust Bancshares
HTB
$758M
| $160K | 0.11% |
10,000
| – | – |
2013 Q2
7 quarters
|
|
|
AVHI
144
DELISTED
A V Homes, Inc.
AVHI
| $160K | 0.11% |
10,000
| – | – |
2013 Q2
7 quarters
|
|
145
Tilly's
TLYS
$139M
| $157K | 0.1% |
+10,000
| New | +$133K |
2015 Q1
0 quarters
|
|
146
ICICI Bank
IBN
$101B
| $155K | 0.1% |
16,500
-11,000
| -40% | -$114K |
2014 Q2
3 quarters
|
|
147
DELISTED
Northfield Bancorp
NFBK
| $148K | 0.1% |
10,000
-20,000
| -67% | -$291K |
2013 Q2
7 quarters
|
|
148
CALL
Opko Health
OPK
$1.03B
| $142K | 0.09% |
+10,000
| New | +$130K |
2015 Q1
0 quarters
|
|
|
INFI
149
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $140K | 0.09% |
10,000
| – | – |
2014 Q2
3 quarters
|
|
150
DELISTED
GENERAL MTRS CO WTS EXP 12/31/15 (DE)
GM.WS.C
| $139K | 0.09% |
105,000
| – | – |
2013 Q3
6 quarters
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q1 2015 Portfolio in Review
As of Q1 2015, E.E. Geduld held 341 positions worth $150M, down 19% from $186M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
E.E. Geduld withdrew a net $46M in Q1 2015, closing 62 positions and reducing 42 holdings. Its most notable exit was Alibaba, an estimated $2.08M position sold in full.
By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 31% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, E.E. Geduld opened a new position in Celgene Corp worth $1.15M.
- E.E. Geduld's largest Q1 2015 buy was Celgene Corp: 10,000 shares worth $1.15M.
- E.E. Geduld added most to PHARMACYCLICS INC in Q1 2015, an estimated $869K increase.
- E.E. Geduld's biggest Q1 2015 reduction was Esperion Therapeutics, cutting an estimated $1.61M.
- E.E. Geduld fully exited Alibaba in Q1 2015, selling an estimated $2.08M.
- E.E. Geduld's ten largest holdings make up 41% of its $150M portfolio in Q1 2015.
- E.E. Geduld opened 79 new positions and closed 62 in Q1 2015.
- E.E. Geduld's portfolio value fell 19% quarter-over-quarter to $150M.
Based on E.E. Geduld's 13F filing for Q1 2015, filed 1 May 2015.